IRLAB Granted Patent For Pirepemat Expanding Patent Protection In The US
18 Sep 2024 //
ACCESSWIRE
IRLAB`s Phase IIb Study Of Pirepemat Proceeds After Positive Safety Review
02 Jul 2024 //
ACCESSWIRE
IRLAB’s Phase IIb Study with Pirepemat - React-PD - Provides New Insights
06 Feb 2024 //
ACCESSWIRE
IRLAB is Granted Additional Patent for Drug Candidate Pirepemat
12 Dec 2023 //
ACCESSWIRE